Last reviewed · How we verify
zirconium-89-labeled RO5479599 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
zirconium-89-labeled RO5479599 (zirconium-89-labeled RO5479599) — Hoffmann-La Roche.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| zirconium-89-labeled RO5479599 TARGET | zirconium-89-labeled RO5479599 | Hoffmann-La Roche | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- zirconium-89-labeled RO5479599 CI watch — RSS
- zirconium-89-labeled RO5479599 CI watch — Atom
- zirconium-89-labeled RO5479599 CI watch — JSON
- zirconium-89-labeled RO5479599 alone — RSS
Cite this brief
Drug Landscape (2026). zirconium-89-labeled RO5479599 — Competitive Intelligence Brief. https://druglandscape.com/ci/zirconium-89-labeled-ro5479599. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab